TherapeuticsMD, Inc. (TXMD) Operating margin 2016–2025
TherapeuticsMD, Inc. (TXMD) operating margin by fiscal year — reported operating income divided by reported revenue.
-145.3%FY2025 · since FY2016: -466.3% → -145.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -145.3% | +201.8 pp |
| FY2024 | -347.1% | +307.5 pp |
| FY2023 | -654.6% | -656.3 pp |
| FY2022 | 1.7% | +3094.5 pp |
| FY2021 | -3092.8% | -2853.0 pp |
| FY2020 | -239.8% | +64.8 pp |
| FY2019 | -304.6% | +504.3 pp |
| FY2018 | -808.8% | -346.2 pp |
| FY2017 | -462.7% | +3.6 pp |
| FY2016 | -466.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice